Clinical Trial Update: A Study of TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection [Phase 3]

View source ↗

Summary

Phase 3 trial of TMC435 for genotype 1 Hepatitis C has completed enrollment. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TMC435

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2014-01-20